Health Care

Paramus company receives FDA approval for COVID-19 clinical trial

“Although many therapies based on provisional data have been proposed for patients who suffer from COVID-19, known treatments are limited,” said Octapharma USA President Flemming Nielsen in a prepared statement. “Intravenous immunoglobulin, which consists of pooled IgG preparations from thousands of donors, has been used to treat patients with immune-mediated diseases for almost 40 years."

Read More »
X-ray of knees.

Hackensack Meridian Health invests in regenerative medicine company EpiBone

“Our industry is going to be transformed by how we leverage cellular biology and new tissue engineering to help the body repair itself, and replace damaged tissue from the impact of chronic and disabling diseases,” said HMH Chief Executive Officer Robert Garrett in a statement. “Our goal is to back innovative evidence-based approaches and products. We are confident in the science, and solutions, EpiBone brings to the market.”

Read More »